Endoscopy 2025; 57(S 02): S136
DOI: 10.1055/s-0045-1805361
Abstracts | ESGE Days 2025
Oral presentation
ERCP outcomes: beyond the mainstream 04/04/2025, 16:45 – 17:45 Room 120+121

Safety of ERCP in Pregnant Women with Biliary Pancreatitis – BORN Study – an International Survey

Authors

  • D Tarján

    1   Institute of Pancreatic Diseases, Semmelweis University, Budapest, Hungary

  • E Szalai

    2   Department of Restorative Dentistry and Endodontics, Semmelweis University, Budapest, Hungary, Budapest, Hungary
    3   Centre for Translational Medicine, Semmelweis University, Budapest, Hungary

  • B Erőss

    3   Centre for Translational Medicine, Semmelweis University, Budapest, Hungary

  • V L Drug

    4   'Grigore T. Popa' University of Medicine and Pharmacy, Iași, Romania

  • S Chooklin

    5   Lviv Regional Clinical Hospital, Lviv, Ukraine

  • M Hirth

    6   Department of Medicine II, Medical Faculty Mannheim, University of Heidelberg, Hidelberg, Germany

  • G Sandblom

    7   2. Dept. of Clinical Science and Education, Karolinska Institutet Södersjukhuset, Stockholm, Sweden

  • V Sandblom

    8   Karolinska Institutet, Stockholm, Sweden

  • A Edergren

    9   Department of Clinical Science and Education Södersjukhuset, Karolinska Institutet, Stockholm, Sweden

  • A Tlili

    10   Department of General Surgery, University Hospital of Gabes, Faculty of Medicine of Sfax, Sfax, Tunisia

  • S Sirtl

    11   Ludwig Maximilian University of Munich, München, Germany

  • LIG D De

    12   University Hospital of Santiago de Compostela, Santiago de Compostela, Spain

  • F Kurti

    13   Department of Gastroenterology and Hepatology, University Hospital Center 'Mother Theresa', Tirana, Albania

  • D Wu

    14   Department of Gastroenterology, Peking Union Medical College Hospital, Beijing, China

  • A Gherbon

    15   Victor Babes University of Medicine and Pharmacy, Timisoara, Romania

  • Ł Nawacki

    16   Collegium Medicum, The Jan Kochanowski University in Kielce, Kiel, Poland

  • A Constantinescu

    17   Gastroenterology Department, Carol Davila University of Medicine and Pharmacy, Bucharest, Romania

  • N Shirinskaya

    18   Omsk Medical and Diagnostic Center «Doverie», Omsk State Medical University, Omsk, Russia

  • S Pandanaboyana

    19   HPB Transplant Unit, Freeman Hospital, Newcastle upon Tyne, United Kingdom

  • T Ikeura

    20   Division of Gastroenterology and Hepatology, Kansai Medical University Hospital, Osaka, Japan

  • G Cúrdia

    21   Gastroenterology Department, Hospital da Senhora da Oliveira, Guimaraes, Portugal

  • L Rasmussen

    22   Department of Surgical Gastroenterology, Hvidovre Hospital, Hvidovre Denmark

  • B Andersson

    23   Department of Surgery Skane University Hospital and Institution for Clinical Sciences Lund, Lund, Sweden

  • A Bouzid

    24   University Tunis El Manar, Tunis, Tunisia

  • N ÁCs

    25   Department of Obstetrics and Gynaecology, Semmelweis University, Budapest, Hungary

  • Z Sípos

    26   Institute for Translational Medicine, Medical School, University of Pécs, Pécs, Hungary

  • M Alexandra

    3   Centre for Translational Medicine, Semmelweis University, Budapest, Hungary

  • P Hegyi

    27   Division of Pancreatic Diseases, Heart and Vascular Center, Semmelweis University, Budapest, Hungary
Weitere Informationen
Auch verfügbar auf
 
 

    Aims Acute biliary pancreatitis in pregnant patients is a rare condition that presents a challenge for clinicians. Endoscopic retrograde cholangiopancreatography (ERCP) is indicated during pregnancy in cases of choledocholithiasis, cholangitis, and some cases of gallstone pancreatitis. This study aimed to investigate the safety and effectiveness of ERCP during acute biliary pancreatitis in pregnancy.

    Methods An international survey was conducted across twenty centres worldwide in 2023 using Excel and Redcap platforms. The survey encompassed questions related to demographic information, clinical presentation, management strategies, including ERCP, timing of cholecystectomy, approaches to the procedure, complications, and outcomes (including recurrence of acute pancreatitis, other gallstone-related complications, and maternal and fetal outcomes). For descriptive statistics, the number of patients, mean, standard deviation (SD), minimum, median, and maximum values were calculated for continuous variables, and case number and percentage were calculated for categorical values. A t-test and the Mann–Whitney U and Mood’s test were used to determine statistical significance.

    Results In this study, pregnant women with biliary acute pancreatitis during pregnancy were included. According to our international survey, 24% (21/88) of the patients had ERCP during their hospitalization. Patients who underwent ERCP had lower rates of readmission (n=4, 19% vs. n=13, 16%; p=0.746), preterm birth (n=1, 5.9% vs. n=8, 12%; p=0.678), and fetal loss (n=2, 9.5% vs. n=4, 4.8%; p=0.345) compared to those who did not. The median gestational age was lower in patients who had ERCP (18 (11, 27) vs. 25 (15, 31)). Furthermore, the ERCP group had more frequent cholangitis and choledocholithiasis (n=9 vs. n=1; n=16 vs. n=7). The median cannulation time was 3 minutes, with a median radiation time of 3.5 minutes. Post-ERCP pancreatitis was diagnosed only in one case. Among patients who had ERCP, cholecystectomy was performed during pregnancy in seven cases.

    Conclusions This is the fourth-largest study evaluating ERCP during biliary pancreatitis in pregnancy. Aligning with the current literature, we found that ERCP is a safe and effective procedure during pregnancy.


     

    Conflicts of Interest

    Authors do not have any conflict of interest to disclose.

    Publikationsverlauf

    Artikel online veröffentlicht:
    27. März 2025

    © 2025. European Society of Gastrointestinal Endoscopy. All rights reserved.

    Georg Thieme Verlag KG
    Oswald-Hesse-Straße 50, 70469 Stuttgart, Germany